Charles Conway - 07 Dec 2017 Form 4/A - Amendment Insider Report for Biohaven Pharmaceutical Holding Co Ltd. (BHVN)

Role
Chief Scientific Officer
Signature
/s/ Jim Engelhart, Attorney-in-Fact
Issuer symbol
BHVN
Transactions as of
07 Dec 2017
Transactions value $
$0
Form type
4/A - Amendment
Filing time
26 Nov 2021, 15:21:01 UTC
Date Of Original Report
11 Dec 2017
Next filing
26 Nov 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BHVN Employee Stock Option (Right to Buy) Award $0 +42.6K $0.00 42.6K 07 Dec 2017 Common Shares 42.6K $20.79 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 11, 2017, the reporting person filed a Form 4 which inadvertently reported that the reporting person was granted 32,612 Employee Stock Options on December 7, 2017. However, as reported in this amendment, the reporting person was actually granted 42,612 Employee Stock Options on such date.
F2 The shares underlying this option vest in four equal installments on December 7, 2018, 2019, 2020 and 2021, subject to the reporting person's continuous service with the issuer at each vesting date.